Transforming the chemotherapy of human African trypanosomiasis

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1. 1Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesienseOriginal Research · 2026
2. 2Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort studyCohort Study · 2021 · 58 citations
3. 3Current Treatments to Control African Trypanosomiasis and One Health PerspectiveOriginal Research · 2022 · 83 citations
4. 4Advances and challenges in the diagnosis of human and animal african trypanosomiasesReview · 2026
5. 5Melarsoprol-Free Drug Combinations for Second-Stage Gambian Sleeping Sickness: The Way to Goeditorial · 2007 · 29 citations
6. 6The elimination of human African trypanosomiasis: Monitoring progress towards the 2021–2030 WHO road map targets2024 · 96 citations
7. 7SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasispreclinical · 2011 · 305 citations
8. 8A plethora of targets, a paucity of drugs: progress towards the development of novel chemotherapies for human African trypanosomiasisReview · 2003 · 11 citations
9. 9Innovative β-lactams and β-lactam/β-lactamase inhibitor combinations against carbapenemase-producing EnterobacteralesClinical Microbiology Reviews · 2026
10. 10Is it tuberculosis or chronic pulmonary aspergillosis? Diagnostic challenges, consequences of misdiagnosis, and potential solutions in resource-limited settingsClinical Microbiology Reviews · 2026